These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34333987)

  • 1. Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling.
    Zhang Y; Su SA; Li W; Ma Y; Shen J; Wang Y; Shen Y; Chen J; Ji Y; Xie Y; Ma H; Xiang M
    Hypertension; 2021 Sep; 78(3):647-660. PubMed ID: 34333987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
    Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
    PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanosensitive Piezo1 channel mediates heart mechano-chemo transduction.
    Jiang F; Yin K; Wu K; Zhang M; Wang S; Cheng H; Zhou Z; Xiao B
    Nat Commun; 2021 Feb; 12(1):869. PubMed ID: 33558521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin.
    Zou Y; Yao A; Zhu W; Kudoh S; Hiroi Y; Shimoyama M; Uozumi H; Kohmoto O; Takahashi T; Shibasaki F; Nagai R; Yazaki Y; Komuro I
    Circulation; 2001 Jul; 104(1):102-8. PubMed ID: 11435346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation.
    de Salvi Guimarães F; de Moraes WM; Bozi LH; Souza PR; Antonio EL; Bocalini DS; Tucci PJ; Ribeiro DA; Brum PC; Medeiros A
    Mol Cell Biochem; 2017 Jan; 424(1-2):87-98. PubMed ID: 27761848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor β₁ oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart.
    Huntgeburth M; Tiemann K; Shahverdyan R; Schlüter KD; Schreckenberg R; Gross ML; Mödersheim S; Caglayan E; Müller-Ehmsen J; Ghanem A; Vantler M; Zimmermann WH; Böhm M; Rosenkranz S
    PLoS One; 2011; 6(11):e26628. PubMed ID: 22125598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling.
    Bush EW; Hood DB; Papst PJ; Chapo JA; Minobe W; Bristow MR; Olson EN; McKinsey TA
    J Biol Chem; 2006 Nov; 281(44):33487-96. PubMed ID: 16950785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin.
    Zhou T; Gao B; Fan Y; Liu Y; Feng S; Cong Q; Zhang X; Zhou Y; Yadav PS; Lin J; Wu N; Zhao L; Huang D; Zhou S; Su P; Yang Y
    Elife; 2020 Mar; 9():. PubMed ID: 32186512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the gating mechanism of the mechanosensitive channel Piezo1 with the small molecule Yoda1.
    Lacroix JJ; Botello-Smith WM; Luo Y
    Nat Commun; 2018 May; 9(1):2029. PubMed ID: 29795280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis.
    Li W; Yang J; Lyu Q; Wu G; Lin S; Yang Q; Hu J
    Mol Cell Biochem; 2020 Jun; 469(1-2):119-132. PubMed ID: 32304004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling.
    Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY
    PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yoda1's energetic footprint on Piezo1 channels and its modulation by voltage and temperature.
    Wijerathne TD; Ozkan AD; Lacroix JJ
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2202269119. PubMed ID: 35858335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic response of cardiac ventricular myocytes to beta-adrenergic stimulation with isoproterenol exhibits diurnal variation: involvement of nitric oxide.
    Collins HE; Rodrigo GC
    Circ Res; 2010 Apr; 106(7):1244-52. PubMed ID: 20167926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
    Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.